LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

Search

Bio-Rad Laboratories Inc

Chiusa

SettoreSettore sanitario

252.6 -1

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

247.98

Massimo

256.51

Metriche Chiave

By Trading Economics

Entrata

780M

64M

Vendite

-82M

585M

EPS

2.54

Margine di Profitto

10.933

Dipendenti

7,700

EBITDA

75M

134M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+25.21% upside

Dividendi

By Dow Jones

Utili prossimi

31 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

435M

7B

Apertura precedente

253.6

Chiusura precedente

252.6

Notizie sul Sentiment di mercato

By Acuity

50%

50%

209 / 382 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

Bio-Rad Laboratories Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 mag 2025, 23:20 UTC

Utili

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

13 mag 2025, 23:48 UTC

Discorsi di Mercato

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

13 mag 2025, 23:43 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

13 mag 2025, 23:43 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

13 mag 2025, 23:24 UTC

Discorsi di Mercato
Utili

Global Equities Roundup: Market Talk

13 mag 2025, 23:24 UTC

Discorsi di Mercato
Utili

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

13 mag 2025, 22:58 UTC

Utili

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mag 2025, 22:58 UTC

Utili

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mag 2025, 22:58 UTC

Utili

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

13 mag 2025, 22:58 UTC

Utili

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

13 mag 2025, 22:38 UTC

Utili

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

13 mag 2025, 22:38 UTC

Utili

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

13 mag 2025, 22:37 UTC

Utili

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

13 mag 2025, 22:36 UTC

Utili

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

13 mag 2025, 22:35 UTC

Utili

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

13 mag 2025, 22:34 UTC

Utili

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

13 mag 2025, 22:33 UTC

Utili

Aristocrat: Interactive Business Delivered Strong Revenue Growth

13 mag 2025, 22:33 UTC

Utili

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

13 mag 2025, 22:33 UTC

Utili

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

13 mag 2025, 22:30 UTC

Utili

Aristocrat Interim Dividend 44 Australian Cents/Share

13 mag 2025, 22:30 UTC

Utili

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

13 mag 2025, 22:29 UTC

Utili

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

13 mag 2025, 22:28 UTC

Utili

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

13 mag 2025, 21:15 UTC

Utili

Nu Holdings 1Q Rev $3.2B >NU

13 mag 2025, 21:03 UTC

Notizie principali

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

13 mag 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

13 mag 2025, 20:32 UTC

Utili

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 mag 2025, 20:31 UTC

Utili

Alcon 1Q Sales $2.45B >ALC.EB

13 mag 2025, 20:30 UTC

Utili

Alcon 1Q Rev $2.47B >ALC.EB

13 mag 2025, 20:30 UTC

Utili

Alcon 1Q EPS 70c >ALC.EB

Confronto tra pari

Modifica del prezzo

Bio-Rad Laboratories Inc Previsione

Obiettivo di Prezzo

By TipRanks

25.21% in crescita

Previsioni per 12 mesi

Media 321.4 USD  25.21%

Alto 392 USD

Basso 270 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Bio-Rad Laboratories Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

5 ratings

3

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

229.835 / 235.8095Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

209 / 382 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.